📰 Wave Life Sciences News
Page 2 - Wave Life Sciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Wave Life Sciences. Real-time updates on events, politics, business and more.
May 2, 2024
A16z Perennial Management L.P. acquired a new stake in Wave Life Sciences Ltd. (NASDAQ:WVE – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 77,619 shares of the company’s stock, valued at approximately $392,000. Wave Life Sciences comprises 0.1% […]
May 2, 2024
CAMBRIDGE, Mass., May 02, 2024 -- Wave Life Sciences Ltd. , a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, will host a...
May 1, 2024
Wave Life Sciences Ltd. (NASDAQ:WVE – Get Free Report)’s share price shot up 5.5% during trading on Wednesday . The company traded as high as $5.30 and last traded at $5.20. 174,697 shares were traded during trading, a decline of 79% from the average session volume of 818,906 shares. The stock had previously closed at […]
April 30, 2024
Proof-of-mechanism data for WVE-006 in individuals with AATD remain on track for 2024CAMBRIDGE, Mass., April 30, 2024 -- Wave Life Sciences Ltd. , a clinical-stage biotechnology company focused on...
April 30, 2024
CAMBRIDGE, Mass., April 30, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human
April 26, 2024
EQS-News: BB BIOTECH AG / Key word: Interim Report BB Biotech presents solid first-quarter results; biotech stock market impacted by shifting views on interest rates...
April 23, 2024
GSK has selected the first two programs to advance following achievement of target validation, marking transition to next phase of research collaboration; programs utilize Wave’s next generation...
April 23, 2024
Wave Life Sciences Ltd. (NASDAQ: WVE) shares moved steadily northward Tuesday, as the clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today provided an update on its best-in-class ...
April 5, 2024
Wave Life Sciences Ltd. (NASDAQ:WVE – Get Free Report)’s stock price fell 3.5% during trading on Wednesday . The stock traded as low as $6.02 and last traded at $6.03. 88,899 shares were traded during trading, a decline of 90% from the average session volume of 907,902 shares. The stock had previously closed at $6.25. […]
April 4, 2024
/PRNewswire/ -- Cadenza Bio, Inc., a pioneering preclinical biotechnology company dedicated to developing innovative small-molecule drugs for the treatment of...